Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pisit Tangkijvanich

Showing results (91-100 of 236) with videos related to

Pageof 24
Sort By:
Antiviral Therapy|March 15, 2017
Association of vitamin-D-related genetic variations and treatment response to pegylated interferon in patients with chronic hepatitis BUmaporn Limothai, Natthaya Chuaypen, Apichaya Khlaiphuengsin, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|July 27, 2013
Hepatitis B virus genetic variation and TP53 R249S mutation in patients with hepatocellular carcinoma in ThailandChureeporn Thongbai, Pattaratida Sa-nguanmoo, Pavanrat Kranokpiruk, et al.
World Journal of Gastroenterology|June 18, 2005
Direct measurement of gastric H+/K+-ATPase activities in patients with or without Helicobacter pylori-associated chronic gastritisDuangporn Thong-Ngam, Pisit Tangkijvanich, Pichet Sampatanukul, et al.
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet|April 8, 2003
Caffeine clearance in patients with hepatocellular carcinoma after transcatheter oily chemoembolization treatmentDuangporn Thong-Ngam, Lakhana Thumvijit, Pisit Tangkijvanich, et al.
Hepato-Gastroenterology|March 12, 2004
Diagnostic role of serum interleukin 6 and CA 19-9 in patients with cholangiocarcinomaPisit Tangkijvanich, Duangporn Thong-ngam, Apiradee Theamboonlers, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 15, 2010
Comparison between quantitative hepatitis B surface antigen, hepatitis B e-antigen and hepatitis B virus DNA levels for predicting virological response to pegylated interferon-alpha-2b therapy in hepatitis B e-antigen-positive chronic hepatitis BPisit Tangkijvanich, Piyawat Komolmit, Varocha Mahachai, et al.
Journal of Gastroenterology|March 18, 2003
SEN virus infection in patients with chronic liver disease and hepatocellular carcinoma in ThailandPisit Tangkijvanich, Apiradee Theamboonlers, Maturapod Sriponthong, et al.
World Journal of Gastroenterology|July 29, 2006
Diagnostic role of serum interleukin-18 in gastric cancer patientsDuangporn Thong-Ngam, Pisit Tangkijvanich, Rungsun Lerknimitr, et al.
Journal of Medical Virology|October 2, 2012
Characterization of hepatitis B virus mutations in untreated patients co-infected with HIV and HBV based on complete genome sequencingPisit Tangkijvanich, Pattaratida Sa-Nguanmoo, Anchalee Avihingsanon, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 5, 2009
Low pretreatment serum HBsAg level and viral mutations as predictors of response to PEG-interferon alpha-2b therapy in chronic hepatitis BPisit Tangkijvanich, Piyawat Komolmit, Varocha Mahachai, et al.
Pageof 24

Showing results (91-100 of 236) with videos related to

Sort By:
Pageof 24
Antiviral Therapy|March 15, 2017
Association of vitamin-D-related genetic variations and treatment response to pegylated interferon in patients with chronic hepatitis BUmaporn Limothai, Natthaya Chuaypen, Apichaya Khlaiphuengsin, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|July 27, 2013
Hepatitis B virus genetic variation and TP53 R249S mutation in patients with hepatocellular carcinoma in ThailandChureeporn Thongbai, Pattaratida Sa-nguanmoo, Pavanrat Kranokpiruk, et al.
World Journal of Gastroenterology|June 18, 2005
Direct measurement of gastric H+/K+-ATPase activities in patients with or without Helicobacter pylori-associated chronic gastritisDuangporn Thong-Ngam, Pisit Tangkijvanich, Pichet Sampatanukul, et al.
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet|April 8, 2003
Caffeine clearance in patients with hepatocellular carcinoma after transcatheter oily chemoembolization treatmentDuangporn Thong-Ngam, Lakhana Thumvijit, Pisit Tangkijvanich, et al.
Hepato-Gastroenterology|March 12, 2004
Diagnostic role of serum interleukin 6 and CA 19-9 in patients with cholangiocarcinomaPisit Tangkijvanich, Duangporn Thong-ngam, Apiradee Theamboonlers, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 15, 2010
Comparison between quantitative hepatitis B surface antigen, hepatitis B e-antigen and hepatitis B virus DNA levels for predicting virological response to pegylated interferon-alpha-2b therapy in hepatitis B e-antigen-positive chronic hepatitis BPisit Tangkijvanich, Piyawat Komolmit, Varocha Mahachai, et al.
Journal of Gastroenterology|March 18, 2003
SEN virus infection in patients with chronic liver disease and hepatocellular carcinoma in ThailandPisit Tangkijvanich, Apiradee Theamboonlers, Maturapod Sriponthong, et al.
World Journal of Gastroenterology|July 29, 2006
Diagnostic role of serum interleukin-18 in gastric cancer patientsDuangporn Thong-Ngam, Pisit Tangkijvanich, Rungsun Lerknimitr, et al.
Journal of Medical Virology|October 2, 2012
Characterization of hepatitis B virus mutations in untreated patients co-infected with HIV and HBV based on complete genome sequencingPisit Tangkijvanich, Pattaratida Sa-Nguanmoo, Anchalee Avihingsanon, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 5, 2009
Low pretreatment serum HBsAg level and viral mutations as predictors of response to PEG-interferon alpha-2b therapy in chronic hepatitis BPisit Tangkijvanich, Piyawat Komolmit, Varocha Mahachai, et al.
Pageof 24